Thursday, August 26

[PL01] Plenary Session 1: Genomics in transplantation

Date & Time	Aug. 26 (Thu.), 09:30-10:30	CH. A
Chair	Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
Presentations	NGS-based MRD Monitoring Pre- and Post-Allogeneic HSCT for AML Michael Heuser (MHH Hospital, Germany ) Conditioning Intensity of Allogeneic Transplantation for AML with MRD Christopher S. Hourigan (NIH, USA)

[PL02] Plenary Session 2: State of the Art in CAR-T Cell Therapy

Date & Time	Aug. 26 (Thu.), 10:40-11:10	CH. A
Chair	Jong Ho Won (Soonchunhyang University College of Medicine, Korea)
Presentation	Engineering and Design for Next Generation CAR-T cells Sham Mailankody (MSKCC, USA)

[PL03] Plenary Session 3: Data Science for Research in Hematopoietic Cell Transplantation

Date & Time	Aug. 26 (Thu.), 11:20-12:20	CH. A
Chair	Young Tak Lim (Pusan National University School of Medicine, Korea)
Presentations	Development and Application of Machine Learning in Hematopoietic Stem Cell Transplantation Yasuyuki Arai (Kyoto University, Japan) Current Statistical Issues in Hematopoietic Cell Transplantation Haesook T. Kim (Dana-Farber Cancer Institute, USA)

[Industry Symposium 1] HANDOK

Date & Time	Aug. 26 (Thu.), 12:40-13:20	CH. A
Chair	Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
Presentation	Mastering the Evolution in Therapy-Related Acute Myeloid Leukemia & Acute Myeloid Leukemia with Myelodysplasia-Related Change Hawk Kim (Gachon University College of Medicine, Korea)

[Industry Symposium 2] Sanofi

Date & Time	Aug. 26 (Thu.), 12:40-13:20	CH. B
Chair	Chang-Ki Min (The Catholic University of Korea, Korea)
Presentation	Optimizing Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Thomas Martin (University of California San Francisco, USA)

[Industry Symposium 3] Bristol-Myers Squibb

Date & Time	Aug. 26 (Thu.), 12:40-13:20	CH. C
Chair	Dong-Wook Kim (The Catholic University of Korea, Korea)
Presentation	Elevating the CML Treatment Goals by Personalizing Treatment with Dasatinib Jeff Lipton (University of Toronto, Canada)

[Industry Symposium 4] Novartis

Date & Time	Aug. 26 (Thu.), 12:40-13:20	CH. C
Chair	Jin Seok Kim (Yonsei University College of Medicine, Korea)
Presentation	KYMRIAH: Rewriting Cancer Survival in DLBCL Michael Dickinson (Peter MacCallum Cancer Cantre, Australia)

[SS01] Scientific Session 1: The Road to Genomics Enlightening the Acute Leukemia with or without BMT

Date & Time	Aug. 26 (Thu.), 14:40-16:10	CH. A
Chairs	Hee-Je Kim (The Catholic University of Korea, Korea) Joon Seong Park (Ajou University School of Medicine, Korea)
Presentations	High Throughput Single Cell Analysis in AML Koichi Takahashi (MDACC, USA) Therapeutic Implications of Genomic Profiling in Acute Myeloid Leukemia Omar Abdel-Wahab (MSKCC, USA) Clonal Hematopiesis of Indeterminate Potential in Transplantation Kyoung Ha Kim (Soonchunhyang University Hospital, Korea)

[Joint Symposium 1] JSTCT-KSBMT: Complication Management after Allo-HSCT

Date & Time	Aug. 26 (Thu.), 14:40-16:20	CH. B
Chairs	Takanori Teshima (Hokkaido University Graduate School of Medicine, Japan) Hoon Kook (Chonnam National University, Korea)
Presentations	Infectious Complication: CMV Infection in Korea Yae Jean Kim (Sungkyunkwan University School of Medicine, Korea) Human Herpesvirus 6B Encephalitis after Allogeneic Stem Cell Transplantation: Diagnostic and Treatment Strategies in Japan Masao Ogata (Oita University, Japan) Gut GVHD-microbiome Dong-Mi Shin (Seoul National University, Korea) Intestinal Dysbiosis and GVHD; Preclinical and Clinical Findings Daigo Hashimoto (Hokkaido University, Japan)

[Education Session 1] Critical Post-transplantation Complications

Date & Time	Aug. 26 (Thu.), 14:40-16:10	CH. C
Chairs	Seong Kyu Park (Soonchunhyang University Bucheon Hospital, Korea) Byung Sik Cho (The Catholic University of Korea, Korea)
Presentations	VOD/SOS: Prophylactic, Preemptive and Curative Treatment Paul Richardson (Dana-Farber Cancer Institute, USA) Transplantation-associated TMA: Pathophysiology, Risk Factors and Management Christopher Dandoy (Cincinnati Children’s Hospital Medical Center, USA) Management of Hemorrhagic Cystitis Ja Min Byun (Seoul National University College of Medicine, Korea)

[Nursing Session 1] Current Status of Blood and Marrow Transplantation and the Role of Nurses(Kor)

Date & Time	Aug. 26 (Thu.), 14:40-16:10	CH. D
Chair	Ji-Na Bok (The Catholic University of Korea, Korea)
Presentations	Current Status of Blood and Marrow Transplantation in Korea Hye youn Lee (Seoul National University College of Medicine, Korea) The Role of Coordinator Nurses in Field of Hematopoietic Stem Cell Transplantation Minjin Choi (Sungkyunkwan University School of Medicine, Korea)

[SS02] Scientific Session 2: Maintenance Treatment Strategies after Allogeneic HSCT in the Novel Agent Era

Date & Time	Aug. 26 (Thu.), 16:30-18:00	CH. A
Chairs	Je-Hwan Lee (University of Ulsan College of Medicine, Korea) Young Rok Do (Keimyung University School of Medicine, Korea)
Presentations	FLT3 Inhibitor Maintenance Therapy after Allogeneic HSCT in FLT3 Mutated AML Richard T. Maziarz (Oregon Health and Science University, USA) Maintenance Therapy (Hypomethylating Agents, Bcl2-Inhibitor, Check Point Inhibitors, and Other Novel Drugs) after Allogeneic HSCT in AML and MDS Tapan Kadia (MDACC, USA) Treatment Stratigies after Allogeneic HSCT in Relapsed ALL Ik-Chan Song (Chungnam National University College of Medicine, Korea)

[SS03] Scientific Session 3: Pediatric ALL

Date & Time	Aug. 26 (Thu.), 16:30-18:00	CH. B
Chairs	Hong Hoe Koo (Sungkyunkwan University School of Medicine, Korea) Hyoung Jin Kang (Seoul National University College of Medicine, Korea)
Presentations	Current Ultimate Choice for Conditioning Regimens Christina Peters (St. Anna Children’s Hospital, Austria) HSCT Incorporation with Non-Traditional Agents: Clofarabine, Treosulfan Franca Fagioli (The University of Turin, Italy) Treatment after Failure of CD-19 Directed Therapy Nirali N. Shah (National Cancer Institute, USA)

[Joint Symposium 2] EBMT-KSBMT: Paradigm Shift in Hodgkin Lymphoma; Bridging Therapy to Allo-HSCT (Novel Agent Before and after Allo-HSCT) and PTCy in Haplo-HSCT

Date & Time	Aug. 26 (Thu.), 16:20-18:00	CH. C
Chairs	Nicolaus Kroeger (University Hospital Hamburg-Eppendorf, Germany) Hoon Kook (Chonnam National University, Korea)
Presentations	Bridging Therapy To Allo-HSCT (Novel Agent before and after Allo-HSCT) Ali Bazarbachi (American University of Beirut, Lebanon) Novel Agents for Relapsed or Refractory Hodgkin Lymphoma in Korea Won Seog Kim (Sungkyunkwan University School of Medicine, Korea) PTCy in Haplo-HSCT in HL Anna Sureda (Institut Català d'Oncologia, Spain) Allo-HSCT in Hodgkin lymphoma in Korea Seok-Goo Cho (The Catholic University of Korea, Korea)

[Case Discussion 1] Adult (Kor)

Date & Time	Aug. 26 (Thu.), 16:30-17:10	CH. D
Chair	Deok Hwan Yang (Chonnam National University Medical School, Korea)
Presentations	Primary CNS Lymphoma Yoon Seok Choi (Ajou University School of Medicine, Korea)

[Case Discussion 2] Pediatric (Kor)

Date & Time	Aug. 26 (Thu.), 17:20-18:00	CH. D
Chair	Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea)
Presentations	Ex Vivo T-cell Depletion vs. PTCy for Upfront Haploidentical Transplantation in Pediatric Very Severe Aplastic Anemia: Ex Vivo TCD Side Sung Han Kang (University of Ulsan College of Medicine, Korea) Ex Vivo T-cell Depletion vs. PTCy for Upfront Haploidentical Transplantation in Pediatric Very Severe Aplastic Anemia: PTCy Side Kyung Taek Hong (Seoul National University College of Medicine, Korea)

Friday, August 27

[SS04] Scientific Session 4: High Risk Multiple Myeloma

Date & Time	Aug. 27 (Fri.), 09:00-10:30	CH. A
Chairs	Ki Hyun Kim (Sungkyunkwan University School of Medicine, Korea) Jin Seok Kim (Yonsei University College of Medicine, Korea)
Presentations	Mass Spectrometry for Detection of Minimal Residual Disease in Multiple Myeloma Noemi Puig (University Hospital of Salamanca, Spain) Role of Tandem Autologous Stem Cell Transplant in High-Risk Patients with Multiple Myeloma Hyeon-Seok Eom (National Cancer Center, Korea) CAR T in Relapsed/Refractory MM” Versus “CAR T in High Risk Nina Shah (The University of California San Francisco, USA)

[Joint Symposium 3] ASTCT-KSBMT: Minimal Residual Disease in Allogeneic HCT or Cellular Therapy

Date & Time	Aug. 27 (Fri.), 09:00-10:30	CH. B
Chairs	John DiPersio (Washington University School of Medicine, USA) Hoon Kook (Chonnam National University, Korea)
Presentations	The Role of Flow-, PCR- and NGS-based MRD in Guiding HCT and CAR T-cell Therapy for Acute Lymphoblastic Leukemia Michael Pulsipher (Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, USA) NGS-based MRD Before and After Allogeneic HCT in Myeloid Neoplasms Myungshin Kim (The Catholic University of Korea, Korea) Molecular Measurable Residual Disease for AML Patients Who Undergoing HSCT Byung Sik Cho (The Catholic University of Korea, Korea)

[SS05] Scientific Session 5: HSCT in Pediatric Non-Malignant Disease

Date & Time	Aug. 27 (Fri.), 09:00-11:00	CH. C
Chairs	Kyung-Ha Ryu (Ewha Womans University College of Medicine, Korea) Nack-Gyun Chung (The Catholic University of Korea, Korea)
Presentations	Treosulfan Based Conditioning for Nonmalignant Diseases Ho Joon Im (University of Ulsan College of Medicine, Korea) Haematopoietic Stem Cell Transplantation and Gene Therapy for Immunodeficiency Andrew Gennery (Newcastle University, UK) Optimizing the Conditioning Regimen of HSCT for Acquired Bone Marrow Failure in Children Nao Yoshida (Japanese Red Cross Nagoya First Hospital, Japan) Bridge to Transplantation for Refractory HLH Michael B Jordan (Cincinnati Children's Hospital Medical Center, USA)

[ES02] Education Session 2: Long Term Management of Allogeneic Stem Cell Transplant Recipients (Kor)

Date & Time	Aug. 27 (Fri.), 09:00-10:30	CH. D
Chairs	Jae-Sook Ahn (Chonnam National University Medical School, Korea) Jae Wook Lee (The Catholic University of Korea, Korea)
Presentations	Nutritional Management in Patients Treated with Stem Cell Transplantation Ka-Won Kang (Korea University College of MedicineM, Korea) Management of Long-Term Endocrine Complications after Hematopoietic Stem Cell Transplantation Jin-Ho Choi (University of Ulsan College of Medicine, Korea) Fertility Preservation and Reproductive Health in Allogeneic Hematopoietic Stem Cell Transplantation Seungmin Hahn (Yonsei University College of Medicine, Korea)

[SS06] Scientific Session 6: New and Emerging Therapeutics for Acute and Chronic GVHD

Date & Time	Aug. 27 (Fri.), 10:50-12:20	CH. A
Chairs	Kyoo-Hyung Lee (University of Ulsan College of Medicine) Deog-Yeon Jo (Chungnam National University College of Medicine, Korea)
Presentations	Ibrutinib and Other B Cell Directed Therapy in Chronic GVHD Corey Cutler (Dana-Farber Cancer Institute, USA) Ruxolitinib for GVHD Management Robert Zeiser (University Medical Center Freiburg, Germany) Intestinal Goblet Cell and IL-25 in Intestinal GVHD Takanori Teshima (Hokkaido University Graduate School of Medicine, Japan)

[Education Session 3] HSCT in Rare Hematologic Malignancies

Date & Time	Aug. 27 (Fri.), 10:50-12:20	CH. B
Chairs	Sung-Hyun Kim (Dong-A University College of Medicine, Korea) Ki-Seong Eom (The Catholic University of Korea, Korea)
Presentations	The Role of Stem Cell Transplantation for WM Masatoshi Sakurai (Keio University, Japan) HSCT in Patients with Blastic Plasmacytic Dendritic Cell Neoplasm Ji Hyun Lee (Dong-A University, Korea) Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis. For Whom, When and How? Chul Won Jung (Sungkyunkwan University School of Medicine, Korea)

[Joint Symposium 4] ISCT-KSBMT: Advances in Biology and Clinical Application of Cellular Therapy: CAR-T Therapy in Solid Malignancy

Date & Time	Aug. 27 (Fri.), 10:50-12:20	CH. D
Chairs	John Rasko (Royal Prince Alfred Hospital, Australia) Je-Jung Lee (Chonnam National University Medical School, Korea)
Presentations	CAR-T Cell Therapy on Pancreatic Cancer John Rasko (Royal Prince Alfred Hospital, Australia) Strategies of CAR-T Cell Therapy to Overcome Challenges in Solid Tumors Baeckseung Lee (MJCELLBIO, Korea) Development of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells against Malignant Glioma Song-Jae Lee (CellabMED Inc., Korea)

[Industry Symposium 5] Astellas Pharma Inc.

Date & Time	Aug. 27 (Fri.), 11:40-12:20	CH. C
Chair	Hee-Je Kim (The Catholic University of Korea, Korea)
Presentation	Optimal Treatment Strategy for FLT3 Mutated AML Andrew Wei (Monash University, Australia)

[Industry Symposium 6] MSD

Date & Time	Aug. 27 (Fri.), 12:30-13:10	CH. A
Chair	Hyeon-Seok Eom (National Cancer Center, Korea)
Presentation	CMV Prophylaxis for Allogeneic HSCT Patients Youngil Koh (Seoul National University College of Medicine, Korea)

[Industry Symposium 7] Kyowa Kirin Co., Ltd.

Date & Time	Aug. 27 (Fri.), 12:30-13:10	CH. B
Chair	Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
Presentation	Updated Treatment Strategy of Immune Thrombocytopenia with TPO Receptor Agonist Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)

[Industry Symposium 8] Janssen

Date & Time	Aug. 27 (Fri.), 12:30-13:10	CH. C
Chair	Je-Jung Lee (Chonnam National University Medical School, Korea)
Presentation	CAR T-Cell Therapies for Multiple Myeloma: Where are We Now and What are the Key Issues? Thomas Martin (University of California San Francisco, USA)

[Industry Symposium 9] Amgen Inc.

Date & Time	Aug. 27 (Fri.), 12:30-13:10	CH. D
Chair	Hyoung Jin Kang (Seoul National University College of Medicine, Korea)
Presentation	Current Strategy for MRD Positive and Relapse ALL Itaru Kato (Kyoto University Hospital, Japan)

[Presidential Symposium]Presidential Symposium

Date & Time	Aug. 27 (Fri.), 14:30-15:10	CH. A
Chair	Hoon Kook (Chonnam National University Medical School, Korea)
Presentation	Making Sense of CAR-T Cell Therapy for Lymphoma David G Maloney (Fred Hutchinson Cancer Research Center, USA)

[SS07] Scientific Session 7: Cell Therapy I (non CAR-T)

Date & Time	Aug. 27 (Fri.), 15:20-16:50	CH. A
Chairs	Seok-Goo Cho (The Catholic University of Korea, Korea) Ho-Jin Shin (Pusan National University School of Medicine, Korea)
Presentations	CAR-NK Cells: A Promising Cellular Immunotherapy for Hematologic Malignancies Jianhua Yu (City of Hope National Medical Center, USA) Adoptive T-Cell Immunotherapy- Experiences in Preclinical and Clinical Studies Tai-Gyu Kim (The Catholic University of Korea, Korea) Novel Immunotherapeutic Approaches with Antibody Drugs Hermann Einsele (University Hospital Würzburg, Germany)

[SS08] Scientific Session 8: Alternative Donor Transplant for SAA

Date & Time	Aug. 27 (Fri.), 15:20-16:50	CH. B
Chairs	Jong Wook Lee (The Catholic University of Korea, Korea) Hawk Kim (Gachon University College of Medicine, Korea)
Presentations	Haploidentical Transplantation with PTCy for SAA Régis Peffault de Latour (Saint-Louis Hospital, France) Haploidentical Transplantation with ATG for SAA Sung-Eun Lee (The Catholic University of Korea, Korea) Immunosuppressive Therapy Versus Haploidentical Transplantation in Adults with SAA Xiao jun Huang (Peking University Institute of Hematology, China

[Education Session 4] Advances in the Laboratory Medicine

Date & Time	Aug. 27 (Fri.), 15:20-16:50	CH. C
Chairs	Myungshin Kim (The Catholic University of Korea, Korea) Young-Uk Cho (University of Ulsan College of Medicine, Korea)
Presentations	Germline Predisposition: an Emerging Issue in Donor Selection for HSCT Lucy Godley (The University of Chicago, USA) NGS-based HLA Typing Yun Ji Hong (Seoul National University College of Medicine, Korea) Chimerism Monitoring Using NGS Assay Hyun-Ji Lee (Pusan National University Yangsan Hospital, Korea)

[Education Session 5] Statistics in HSCT (Kor)

Date & Time	Aug. 27 (Fri.), 15:20-16:50	CH. D
Chair	Joon Ho Moon (Kyungpook National University School of Medicine, Korea)
Presentations	Statistical Methods in HSCT Hwa Jung Kim (Asan Medical Center, Korea) Designing Clinical Studies in the HSCT Setting Seokyung Hahn (Seoul National University College of Medicine, Korea)

Saturday, August 28

[SS09] Scientific Session 9: Cell Therapy II (CAR-T)

Date & Time	Aug. 28 (Sat.), 09:00-10:30	CH. A
Chairs	Je-Jung Lee (Chonnam National University Medical School, Korea) Duck Cho (Sungkyunkwan University School of Medicine, Korea)
Presentations	Off the shelf' CAR-T Cells for Relapsed Refractory Lymphoma and MM Sattva S Neelapu (The University of Texas M.D. Anderson Cancer Center, USA) Use of CAR -T Cells in Allogeneic Stem Cell Transplantation Peihua Lu (Lu Daopei hospital, China) Real World Experience of CAR-T Cells in Korea Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)

[SS10] Scientific Session 10: The Role of Stem Cell Transplantation in Lymphoma in the Era of Novel and Cell Therapy

Date & Time	Aug. 28 (Sat.), 09:00-10:30	CH. B
Chairs	Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea) Dok Hyun Yoon (Ulsan University College of Medicine, Korea)
Presentations	Autologous Stem Cell Transplantation for Aggressive B-cell Lymphomas in the Frontline Setting: Current Controversies and Advances Narendranath Epperla (The Ohio State University Comprehensive Cancer Center, USA) High Dose Therapy and Autologous Stem Cell Transplantation in Patients with Indolent Lymphoma Julie M. Vose (University of Nebraska Medical Center, USA) The Role of Allogeneic Stem Cell Transplantation for Relapsed and Refractory Lymphoma in the Era of CAR-T Cell Therapy Youngwoo Jeon (The Catholic University of Korea, Korea)

[SS11] Scientific Session 11: Best Donor for Allogeneic HSCT: Beyond Matched Sibling Donor

Date & Time	Aug. 28 (Sat.), 09:00-10:30	CH. C
Chairs	Ho Joon Im (University of Ulsan College of Medicine, Korea) Chul Won Choi (Korea University School of Medicine, Korea)
Presentations	Comparison of Allogeneic Stem Cell Transplantation from Matched Unrelated Donor (URD) and Haploidentical Family Donor (HFD) in Adults with Hematological Malignancies Focusing on Acute Leukemia Arnon Nagler (Tel Aviv University, Israel) Cord blood Versus Haploidentical Stem Cell Transplantation for Hematological Malignancie Jae-Ho Yoon (The Catholic University of Korea, Korea) Unrelated Donor vs Haploidentical αβ T-cell- and B-cell-depleted HSCT in Children with Acute Leukemia Alice Bertaina (Stanford School of Medicine, USA)

[Nursing Session 2] New Therapy of Hematology and Stem Cell Transplantation(Kor)

Date & Time	Aug. 28 (Sat.), 09:00-10:30	CH. C
Chair	Mi-ok Choi (Yonsei University College of Medicine, Korea)
Presentations	Updated View on the Treatment of Hemato-Oncology Ja Min Byun (Seoul National University College of Medicine, Korea) Introduction of CAR-T Therapy Sang Eun Yoon (Sungkyunkwan University School of Medicine, Korea)

[SS12] Scientific Session 12: Donor Lymphocyte Infusion after HSCT

Date & Time	Aug. 28 (Sat.), 10:40-12:10	CH. A
Chairs	Chuhl Joo Lyu (Yonsei University College of Medicine, Korea)
Presentations	Prophylactic/preemptive DLI: Real World Experience Xiao jun Huang (Peking University Institute of Hematology, China) Therapeutic DLI in Relapsed/Refractory Hematologic Malignancy Bhagirathbhai Dholaria (Vanderbilt University Medical Center, USA) Post-transplantation Cyclophosphamide based Haploidentical Transplantation and Donor Lymphocyte Infusion Hyoung Jin Kang (Seoul National University College of Medicine, Korea)

[SS13] Scientific Session 13: Advancing Science Together for a Better Future of HSCT

Date & Time	Aug. 28 (Sat.), 10:40-12:10	CH. B
Chairs	Hoon Kook (Chonnam National University Medical School, Korea) Jae-Yong Kwak (Chonbuk National University Medical School, Korea)
Presentations	Error-corrected Next Generation Sequencing to Detect MRD in AML Nikhil Patkar (Tata Memorial Centre, India) Haploidentical CD19 CAR-T Cell for Treatment of Relapsed Refractory ALL Suradej Hongeng (Mahidol University, Thailand) Hematopoietic Stem Cell Transplantation Have Relation with Clinical Phenotype of Fanconi Anemia Patients: Iranian Experience Amir Ali Hamidieh (Tehran University of Medical Sciences, Iran)

[Joint Symposium 5] TSBMT-KSBMT: Second Malignancies after Allo-HSCT & Auto-HSCT

Date & Time	Aug. 28 (Sat.), 10:40-12:10	CH. C
Chairs	Hasan Atilla Özkan (Yeditepe University Hospital, Turkey) Young Tak Lim (Pusan National University School of Medicine, Korea)
Presentations	Second Malignancies after Allo-HSCT & Auto-HSCT in Turkey Huseyin Saffet Bekoz (Medipol University Hospital, Turkey) Secondary Maligancy Following Allogeneic Stem Cell Transplantaiton in Adult Patients Seung-Hwan Shin (The Catholic University of Korea, Korea)

[RL01] Student/Resident Lecture (kor)

Date & Time	Aug. 28 (Sat.), 10:40-12:10	CH. D
Chairs	Won Sik Lee (Inje University School of Medicine, Korea) Young-Ho Lee (Hanyang University College of Medicine, Korea)
Presentations	Current Progress in Cellular Immunotherapy for Hematologic Malignancies Sung-Hoon Jung (Chonnam National University Hwasun Hospital, Korea) Understanding the Role of Genetics in Hematologic Malignancies Saeam Shin (Yonsei University, Korea) Long-term Management in Pediatric Patients after HSCT Eu Jeen Yang (Pusan National University School of Medicine, Korea)